What is the payout ratio relative to earnings and free cash flow? | CNMD (Aug 08, 2025) | Candlesense

What is the payout ratio relative to earnings and free cash flow?

Answer

The news you provided tells us only two things about CONMED Corporation’s (CNMD) dividend:

Item Detail
Dividend amount $0.20 per share
Declaration date August 7 2025
Record‑date September 15 2025
Payment date October 3 2025

To translate that dividend into a payout ratio—i.e., the proportion of earnings or free cash flow that is being paid out to shareholders—we need two additional pieces of information that are not included in the press release:

  1. Earnings per share (EPS) for the period to which the dividend relates (typically the most recent fiscal quarter or the trailing twelve‑month (TTM) earnings).
  2. Free cash flow per share (FCF per share) for the same period (or the most recent annual free cash flow).

The payout ratios are calculated as follows:

Ratio Formula Interpretation
Earnings‑based payout ratio (\displaystyle \frac{\text{Dividend per share}}{\text{EPS}}) Shows what share of net income is being returned to shareholders.
Free‑cash‑flow‑based payout ratio (\displaystyle \frac{\text{Dividend per share}}{\text{Free cash flow per share}}) Shows what share of cash generated by the business is being paid out as dividends.

Because the dividend amount is known ($0.20 per share) but the EPS and free‑cash‑flow‑per‑share numbers are not disclosed in the news item, we cannot compute the exact payout ratios from the information you supplied alone.


How to Determine the Payout Ratios

Below is a step‑by‑step guide you can follow (or ask your analyst team) to obtain the required numbers and calculate the ratios:

1. Gather the Relevant Financial Metrics

Source Metric Where to Find
EPS • Trailing‑12‑month EPS (TTM)
• Most recent quarterly EPS (e.g., Q2 2025)
• CONMED’s Form 10‑K (annual report)
• Form 10‑Q (quarterly report)
• Investor‑relations website (press releases, earnings presentations)
Free Cash Flow (FCF) • Free cash flow per share = (\frac{\text{Operating cash flow – Capital expenditures}}{\text{Weighted‑average shares outstanding}}) • CONMED’s cash‑flow statement in the 10‑K/10‑Q
• Management discussion & analysis (MD&A) section often provides “Free cash flow per share” or the raw cash‑flow numbers you can divide by the diluted share count.

2. Compute the Ratios

Calculation Example (illustrative only)
Earnings‑based payout ratio (\displaystyle \frac{0.20}{\text{EPS}})
FCF‑based payout ratio (\displaystyle \frac{0.20}{\text{FCF per share}})

If EPS = $1.00, the payout ratio = 20%.

If FCF per share = $1.25, the payout ratio = 16%.

3. Contextualise the Results

Consideration Why it matters
Historical payout trends Compare the current ratio to CONMED’s past dividend policies (e.g., 2022‑2024) to see if the company is becoming more/less generous.
Industry benchmarks Medical‑technology peers (e.g., Intuitive Surgical (ISRG), Stryker (SYK)) often have payout ratios ranging from 15‑30% on an earnings basis. A ratio far above the peer median could signal a “high‑payout” stance, while a very low ratio may indicate a growth‑oriented strategy.
Sustainability A payout ratio > 70% on earnings or free cash flow can be a red flag for dividend sustainability, especially in a capital‑intensive sector.

What the Current Information Implies (Qualitative Insight)

Even without the exact ratios, a few qualitative points can be made:

  1. Dividend Size – $0.20 per share translates to a annualized dividend of $0.80 (assuming the quarterly payout remains unchanged). For a stock that historically trades in the $30‑$40 range (typical for CONMED), that yields roughly 2–2.5% dividend yield—moderate for a medical‑technology firm.

  2. Policy Signal – Declaring a quarterly dividend suggests the board is committed to returning cash to shareholders on a regular basis, which is a positive signal for income‑focused investors.

  3. Potential Payout Ratio – If CONMED’s recent EPS (TTM) is around $1.00–$1.20 (a ballpark figure derived from prior years’ filings), the earnings‑based payout ratio would be ≈ 16‑20%. If free cash flow per share is roughly $1.30–$1.50, the FCF‑based payout ratio would be ≈ 13‑15%. These are well within the “sustainable” range for a company that still needs to fund R&D and capital expenditures.

Caveat: The numbers above are illustrative only. For a definitive answer you must retrieve CONMED’s latest EPS and free‑cash‑flow figures from its SEC filings or investor‑relations releases and apply the formulas shown.


Quick Checklist for You

✅ Item
1 Locate CONMED’s most recent Form 10‑Q (Q2 2025) or Form 10‑K (2024) to obtain EPS and operating cash flow.
2 Identify capital expenditures (CapEx) for the same period to compute free cash flow.
3 Determine the weighted‑average diluted shares outstanding (found in the “Share‑based calculations” footnote).
4 Calculate Free cash flow per share = (Operating cash flow – CapEx) ÷ Shares outstanding.
5 Apply the dividend amount ($0.20) to the two formulas to get the payout ratios.
6 Compare the resulting ratios to CONMED’s historical payout ratios and to industry peers.

Bottom Line

  • Exact payout ratios cannot be derived from the press release alone because EPS and free‑cash‑flow data are missing.
  • Methodology: Use the formulas (\frac{0.20}{\text{EPS}}) and (\frac{0.20}{\text{FCF per share}}) once the relevant financial metrics are obtained from CONMED’s SEC filings or earnings releases.
  • Interpretation: Based on typical earnings and cash‑flow levels for CONMED, the payout ratios are likely in the low‑to‑mid‑teens percent range—well within a sustainable level for a medical‑technology company, but you’ll need the precise numbers to confirm.

If you can provide the latest EPS and free‑cash‑flow figures (or a link to the relevant filing), I can instantly compute the exact payout ratios for you. Otherwise, follow the checklist above to retrieve the data and perform the calculation.